Wittgen Biotechnologies
Turning single-cell clarity into cancer therapeutic opportunity through AI, WittGen develops a Single-Cell Cancer Drug Discovery & development Gen AI/ML Accelerator, LEIBER-X that boosts novel target/biomarker discovery, MoA monitoring and patient stratification, ensuring new drug success at cellular-level resolution. Our platform provides tailored companion diagnostics to optimize cancer treatment outcomes. Make Every Cell Counts!
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Wittgen Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- YR
Yun Rhie
Founder & CEO · General Business & Management
EmailPhone - JP
Jaeeun Park
Bioinformatician · Research & Development
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Wittgen Biotechnologies
3 distinct titles indexed · top 3 shown.
- 1back end software engineer
- 1bioinformatician
- 1founder & ceo
Sign up to unlock all 4 contacts at Wittgen Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Wittgen Biotechnologies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.